Cormorant Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $3.05M | Sell |
|
|||||
|
2021
Q2 | $4.84M | Sell |
|
|||||
|
2021
Q1 | $22.7M | Sell |
|
|||||
|
2020
Q4 | $30.7M | Sell |
|
|||||
|
2020
Q3 | $66.9M | Sell |
|
|||||
|
2020
Q2 | $40.8M | Buy |
|
|||||
|
2020
Q1 | $9.2M | Buy |
|
|||||
|
2019
Q4 | $13.5M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $3.38M | Hold |
|
|||||
|
2017
Q1 | $6.68M | Sell |
|
|||||
|
2016
Q4 | $9.35M | Sell |
|
|||||
|
2016
Q3 | $16.4M | Hold |
|
|||||
|
2016
Q2 | $11.9M | Buy |
|
|||||
|
2016
Q1 | $11.3M | Hold |
|
|||||
|
2015
Q4 | $18.3M | Hold |
|
|||||
|
2015
Q3 | $17.6M | Buy |
|
|||||
|
2015
Q2 | $34.3M | Buy |
|
|||||
|
2015
Q1 | $19.1M | Sell |
|
|||||
|
2014
Q4 | $17.6M | Buy |
|
|||||
|
2014
Q3 | $4.52M | Hold |
|
|||||
|
2014
Q2 | $6.75M | Buy |
|
|||||
|
2014
Q1 | $8.97M | Buy |
|